
No results matched your search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | NYSE | USD | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GLAXF | OTC Markets | USD | Delayed | |
GSK | Derived | GBP | Real-time | |
GSK | London | GBP | Real-time | |
GSKN | Mexico | MXN | Delayed | |
GSK | Xetra | EUR | Delayed | |
GSK | TradeGate | EUR | Delayed | |
GSK | Frankfurt | EUR | Delayed | |
GSKy | Frankfurt | EUR | Delayed | |
GSK | Buenos Aires | ARS | Delayed |
The National Institutes of Health said Thursday that it stopped enrollment in two clinical trials evaluating experimental COVID-19 therapies after discovering they likely do not...
Shares of Vir Biotechnology Inc. tumbled 5.4% in premarket trading on Thursday, the day after the company said the experimental COVID-19 treatment that it's developing with...
Vir Biotechnology (VIR),down 17% premarketand GlaxoSmithKline (GSK) provide an update on the VIR-7831 (GSK4182136) arm of the AcceleratingCOVID-19 Therapeutic Interventions and...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Neutral | Strong Sell |
Summary | Strong Buy | Strong Buy | Strong Buy | Neutral | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Advance Block Bearish | 15 | Current | |||
Bullish Engulfing | 1W | Current | |||
Completed Patterns | |||||
Three Inside Up | 5H | 1 | Mar 05, 2021 12:00 | ||
Engulfing Bearish | 5H | 3 | Mar 04, 2021 16:00 | ||
Doji Star Bearish | 1H | 4 | Mar 05, 2021 17:00 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NYSE | 34.91 | 34.90 | 35.00 | 6,448,427 | +1.84% | USD | 05/03 | ||
BATS Europe | 1,219.14 | 0.00 | 0.00 | 2,856,261 | +1.49% | GBP | 05/03 | ||
OTC Markets | 17.0000 | 0.0000 | 0.0000 | 513 | +2.29% | USD | 05/03 | ||
Real-time derived | 1,245.0 | - | - | - | +1.67% | GBP | 05/03 | ||
London | 1,243.00 | 1,225.60 | 1,250.00 | 10,011,271 | +1.54% | GBP | 05/03 | ||
Mexico | 735.00 | 735.01 | 748.99 | 257 | +2.80% | MXN | 05/03 | ||
Xetra | 14.590 | 14.510 | 14.600 | 226,296 | +1.87% | EUR | 05/03 | ||
TradeGate | 14.65 | 14.56 | 14.65 | 76,660 | +2.72% | EUR | 05/03 | ||
Frankfurt | 14.58 | 0.00 | 0.00 | 14,230 | +1.59% | EUR | 05/03 | ||
Frankfurt | 28.400 | 0.000 | 0.000 | 0 | -0.70% | EUR | 05/03 | ||
Buenos Aires | 1,320.00 | 1,280.00 | 1,600.00 | 322 | +2.40% | ARS | 05/03 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Zenith Bank | 25.30 | 25.40 | 24.95 | 0.00 | 0.00% | 46.85M | 05/03 | ||
FBN Holdings | 7.10 | 7.10 | 6.85 | +0.05 | +0.71% | 26.50M | 05/03 | ||
Guaranty Trust Bank | 31.20 | 31.05 | 30.90 | -0.50 | -1.59% | 20.83M | 05/03 | ||
UBA | 7.95 | 7.95 | 7.85 | 0.00 | 0.00% | 23.30M | 05/03 | ||
MTN Nigeria | 160.20 | 160.20 | 160.20 | -9.80 | -5.76% | 643.20K | 05/03 | ||
Oando Plc | 2.65 | 3.00 | 2.65 | -0.25 | -8.62% | 4.05M | 05/03 | ||
Access Bank | 7.90 | 7.85 | 7.70 | +0.10 | +1.28% | 10.47M | 05/03 | ||
Fidson | 4.650 | 4.650 | 4.650 | +0.240 | +5.44% | 162.29K | 05/03 | ||
Japaul Gold Ventures | 0.51 | 0.50 | 0.48 | -0.04 | -7.55% | 12.46M | 05/03 | ||
Julius Berger | 18.70 | 18.80 | 18.80 | +0.10 | +0.53% | 329.30K | 05/03 |
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review